LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 42

Search options

  1. Article ; Online: Addiction, Race, and the Structurally Vulnerable.

    Jegede, Oluwole

    The American journal on addictions

    2020  Volume 29, Issue 5, Page(s) 428–429

    Language English
    Publishing date 2020-09-09
    Publishing country England
    Document type Journal Article
    ZDB-ID 1141440-6
    ISSN 1521-0391 ; 1055-0496
    ISSN (online) 1521-0391
    ISSN 1055-0496
    DOI 10.1111/ajad.13090
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Systemic Racism as a Determinant of Health Inequities for People With Substance Use Disorder.

    Jegede, Oluwole / Bellamy, Chyrell / Jordan, Ayana

    JAMA psychiatry

    2024  Volume 81, Issue 3, Page(s) 225–226

    MeSH term(s) Humans ; Systemic Racism ; Health Inequities ; Substance-Related Disorders ; Racism
    Language English
    Publishing date 2024-01-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2701203-7
    ISSN 2168-6238 ; 2168-622X
    ISSN (online) 2168-6238
    ISSN 2168-622X
    DOI 10.1001/jamapsychiatry.2023.4958
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Chronic use of benzodiazepines: The problem that persists.

    Louie, Dexter L / Jegede, Oluwole O / Hermes, Gretchen L

    International journal of psychiatry in medicine

    2023  Volume 58, Issue 5, Page(s) 426–432

    Abstract: Though clinical guidelines and policies discourage the chronic prescribing of benzodiazepines, rates of prescribing have continued to rise in the United States with an estimated 65.9 million office visits per year made for this purpose. Quietly, we have ... ...

    Abstract Though clinical guidelines and policies discourage the chronic prescribing of benzodiazepines, rates of prescribing have continued to rise in the United States with an estimated 65.9 million office visits per year made for this purpose. Quietly, we have become a nation on benzodiazepines. There are numerous reasons for this discrepancy between official recommendations on the one hand, and actual clinical practice on the other. Drawing from the literature, we argue that while patients and providers both shoulder some of the responsibility, they cannot be solely blamed. Rather, policies and guidelines regarding benzodiazepine prescribing have become out of touch with the clinical reality that benzodiazepines are now deeply entrenched in modern medicine. We propose that guidelines regarding benzodiazepines need to reconsider how to apply concepts such as harm reduction and other lessons learned in the opioid epidemic in order to help physicians manage this increasingly pressing problem affecting millions of Americans.
    MeSH term(s) Humans ; United States/epidemiology ; Benzodiazepines/adverse effects ; Drug Prescriptions ; Practice Patterns, Physicians' ; Analgesics, Opioid/therapeutic use
    Chemical Substances Benzodiazepines (12794-10-4) ; Analgesics, Opioid
    Language English
    Publishing date 2023-03-27
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 220669-9
    ISSN 1541-3527 ; 0091-2174
    ISSN (online) 1541-3527
    ISSN 0091-2174
    DOI 10.1177/00912174231166252
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Building Outreach and Diversity in the Field of Addictions.

    Jordan, Ayana / Jegede, Oluwole

    The American journal on addictions

    2020  Volume 29, Issue 5, Page(s) 413–417

    Language English
    Publishing date 2020-09-09
    Publishing country England
    Document type Journal Article
    ZDB-ID 1141440-6
    ISSN 1521-0391 ; 1055-0496
    ISSN (online) 1521-0391
    ISSN 1055-0496
    DOI 10.1111/ajad.13097
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Buprenorphine Treatment of Fentanyl-Related Opioid Use Disorder.

    Jegede, Oluwole / Parida, Suprit / De Aquino, Joao P

    The primary care companion for CNS disorders

    2022  Volume 24, Issue 3

    MeSH term(s) Buprenorphine/therapeutic use ; Fentanyl/adverse effects ; Humans ; Opiate Substitution Treatment ; Opioid-Related Disorders/drug therapy
    Chemical Substances Buprenorphine (40D3SCR4GZ) ; Fentanyl (UF599785JZ)
    Language English
    Publishing date 2022-04-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2675414-9
    ISSN 2155-7780 ; 2155-7780
    ISSN (online) 2155-7780
    ISSN 2155-7780
    DOI 10.4088/PCC.21cr03163
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: A Review of the Mental Health Sequelae of the SARS-CoV-2 (COVID-19): Preparedness Perspective.

    Metellus, Peterson / Jegede, Oluwole / Brown, Colvette / Qureshi, Danish / Nkemjika, Stanley

    Cureus

    2023  Volume 15, Issue 4, Page(s) e37643

    Abstract: Despite the three significant epidemics that have rattled the world in the last two decades, many questions remain unanswered! The concept of unwanted psychological distress remains looming after any epidemic or pandemic. The public health burden of the ... ...

    Abstract Despite the three significant epidemics that have rattled the world in the last two decades, many questions remain unanswered! The concept of unwanted psychological distress remains looming after any epidemic or pandemic. The public health burden of the COVID-19 pandemic still resonates with different aspects of life with predicted mental health sequelae. This review will focus on the role of natural disasters and past infectious epidemic-related mental health complications. Additionally, the study provides recommendations and policy suggestions for mitigating COVID-19-related mental health prevalence.
    Language English
    Publishing date 2023-04-16
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.37643
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Mental health problems of black and white children in a nationally representative epidemiologic survey.

    Bommersbach, Tanner / Rhee, Taeho Greg / Jegede, Oluwole / Rosenheck, Robert A

    Psychiatry research

    2023  Volume 321, Page(s) 115106

    Abstract: Black children face more numerous socio-economic disadvantages than White children, but whether they have more adverse mental health problems remains understudied. Using nationally-representative data from the 2018-2019 National Survey of Children's ... ...

    Abstract Black children face more numerous socio-economic disadvantages than White children, but whether they have more adverse mental health problems remains understudied. Using nationally-representative data from the 2018-2019 National Survey of Children's Health, we examined differences in mental health problems between non-Hispanic Black (n = 2,890) and White (n = 30,015) children aged 6-17. Multivariate analyses were used to determine whether differences in mental health conditions could be accounted for by other factors. We found Black children were significantly less likely than White children to have clinically-identified internalizing conditions (especially anxiety) and more likely to be identified with conduct problems. Black children were also substantially more likely to have greater exposure to adverse childhood experiences (ACEs), to be uninsured, experience poverty, and less likely to receive needed mental health services. After adjusting for these potential confounders, Black children remained half as likely to have clinically-recognized internalizing conditions, but were no longer more likely to have clinically-identified conduct problems. Differences in ACEs alone fully accounted for the racial difference in conduct problems. These results point to the potential impact of assessment bias by clinicians and underscore the potential benefit of routine screening for depression/anxiety in racial/ethnic minority children, especially in light of rising suicide rates among Black youth.
    MeSH term(s) Adolescent ; Child ; Humans ; Ethnicity ; Mental Health/ethnology ; Minority Groups ; White ; Black or African American
    Language English
    Publishing date 2023-02-10
    Publishing country Ireland
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 445361-x
    ISSN 1872-7123 ; 1872-7506 ; 0925-4927 ; 0165-1781
    ISSN (online) 1872-7123 ; 1872-7506
    ISSN 0925-4927 ; 0165-1781
    DOI 10.1016/j.psychres.2023.115106
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Multimorbidity and Correlates of Comorbid Depression and Generalized Anxiety Disorder in a Nationally Representative US Sample.

    Jegede, Oluwole / Stefanovics, Elina A / Rhee, Taeho Greg / Rosenheck, Robert A

    The Journal of nervous and mental disease

    2023  Volume 211, Issue 5, Page(s) 355–361

    Abstract: Abstract: Generalized anxiety disorder (GAD) and major depressive disorder (MDD) frequently occur together, but sociodemographic, behavioral, and diagnostic correlates of this comorbidity have not been comprehensively studied. Data from the nationally ... ...

    Abstract Abstract: Generalized anxiety disorder (GAD) and major depressive disorder (MDD) frequently occur together, but sociodemographic, behavioral, and diagnostic correlates of this comorbidity have not been comprehensively studied. Data from the nationally representative US sample surveyed in the National Epidemiologic Survey on Alcohol and Related Conditions-III ( N = 36,309) were used to define three groups, individuals with a) both past-year GAD and MDD ( n = 909, 16.9%), b) GAD only ( n = 999, 18.6%), and c) MDD only ( n = 3471, 64.5%). The comorbid group was compared with each single-diagnosis group on sociodemographic, behavioral, and diagnostic characteristics based on effect sizes (risk ratios and Cohen's d ) rather than p values because of the large sample sizes. Multivariable-adjusted logistic regression analyses were used to identify factors independently associated with the comorbid group. Bivariate analysis showed that the comorbid group had more parental and childhood adversities, additional psychiatric disorders, and poorer mental health quality of life than both single-disorder groups. Multivariable-adjusted logistic regression of the comorbid group showed that on two of five factors, additional psychiatric diagnoses were significantly more frequent than in the GAD-only group, and that on three of six factors, additional psychiatric diagnoses were significantly more frequent than in the MDD-only group. There is a significantly higher burden of social adjustment problems, comorbid psychiatric disorders, and poorer mental health-related quality of life among individuals with comorbid GAD-MDD than those with single disorders. The adversities associated with this non-SUD psychiatric comorbidity are comparable to those associated with the more extensively studied comorbidity of psychiatric and substance use disorders and deserve further research and treatment.
    MeSH term(s) Humans ; Child ; Depressive Disorder, Major/epidemiology ; Multimorbidity ; Quality of Life ; Depression ; Comorbidity ; Anxiety Disorders/psychology
    Language English
    Publishing date 2023-02-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3020-x
    ISSN 1539-736X ; 0022-3018
    ISSN (online) 1539-736X
    ISSN 0022-3018
    DOI 10.1097/NMD.0000000000001625
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Community based buprenorphine micro-induction in the context of methadone maintenance treatment and fentanyl - Case report.

    Kaliamurthy, Sivabalaji / Jegede, Oluwole / Hermes, Gretchen

    Journal of addictive diseases

    2022  Volume 41, Issue 2, Page(s) 175–180

    Abstract: Introduction: The micro-induction method of initiating buprenorphine is becoming a popular method for initiating buprenorphine in patients with Opioid Use Disorder, who are on full opioid agonists, either prescribed or non-prescribed, in order to avoid ... ...

    Abstract Introduction: The micro-induction method of initiating buprenorphine is becoming a popular method for initiating buprenorphine in patients with Opioid Use Disorder, who are on full opioid agonists, either prescribed or non-prescribed, in order to avoid precipitated withdrawal. Given the rising concerns around illicit fentanyl use, this method of initiating buprenorphine has become another tool for clinicians to help patients with Opioid Use Disorder, even when multiple full opioid agonists are involved. While the process for initiating buprenorphine through this process is well studied, the characteristics of patients who are able to tolerate this initiation method in an outpatient setting is not.
    Case(s): We present the cases of two patients with Opioid Use Disorder in a community-based methadone maintenance program in whom micro-induction methods were used to initiate buprenorphine without lowering the methadone dose. Both patients successfully transitioned to buprenorphine without precipitated withdrawal. One of the patients was also using fentanyl at the time of induction and was able to abstain from fentanyl use following the induction process.
    Conclusion: Initiating Buprenorphine using micro-induction strategies in a community based outpatient clinic in patients who are already on full opioid agonists is feasible, in these particular cases, the methadone dose or concurrent fentanyl use did not affect the outcome. We present the characteristics of the patient and the community clinic hoping that this helps more clinicians in replicating this induction strategy.
    MeSH term(s) Humans ; Buprenorphine/therapeutic use ; Methadone/therapeutic use ; Analgesics, Opioid/therapeutic use ; Fentanyl/therapeutic use ; Opiate Substitution Treatment/methods ; Opioid-Related Disorders/drug therapy ; Opioid-Related Disorders/rehabilitation
    Chemical Substances Buprenorphine (40D3SCR4GZ) ; Methadone (UC6VBE7V1Z) ; Analgesics, Opioid ; Fentanyl (UF599785JZ)
    Language English
    Publishing date 2022-04-04
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 1077616-3
    ISSN 1545-0848 ; 1055-0887
    ISSN (online) 1545-0848
    ISSN 1055-0887
    DOI 10.1080/10550887.2022.2051985
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Depression and/or PTSD Comorbidity Affects Response to Antidepressants in Those With Alcohol Use Disorder.

    Na, Peter J / Ralevski, Elizabeth / Jegede, Oluwole / Wolfgang, Aaron / Petrakis, Ismene L

    Frontiers in psychiatry

    2022  Volume 12, Page(s) 768318

    Abstract: Objective: ...

    Abstract Objective:
    Language English
    Publishing date 2022-01-04
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2564218-2
    ISSN 1664-0640
    ISSN 1664-0640
    DOI 10.3389/fpsyt.2021.768318
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top